Is your melanoma hot enough for immunotherapy?
Source: Science Daily, May 2019 Melanomas tend to be “hot" or “cold" — if they’re hot, immunotherapy lights melanoma tumors like beacons for elimination by the immune system; but 40-50…
Read More Regulatory
Novel Immunotherapy Tebentafusp Granted Fast Track Designation for Metastatic Uveal Melanoma
Source: Targeted Oncology, May 2019 The FDA has granted tebentafusp (IMCgp100) a fast track designation for the treatment of patients with HLA-A*0201-positive previously untreated metastatic uveal melanoma, according to Immunocore…
Read More FDA Approves Keytruda for Melanoma Patients After Tumor Resection
Source: Immuno-Oncology News, March 2019 The U.S. Food and Drug Administration has approved the use of Keytruda(pembrolizumab) as a treatment for melanoma patients with stage 3 disease — cancer cells have…
Read More NICE recommends new treatment for unresectable or metastatic melanoma with a BRAF V600 mutation
Source: Pharma Field, February 2019 NICE recommends new treatment for adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation. Pierre Fabre welcomes the National Institute for Health…
Read More